Varaico: Literature-Extracted Genetic Variants

Gene:SCN2A
Variant:p.D82G
Back to variants list

SCN2A

NM_001040142.2:p.D82G

Associated Papers

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.

Tan M et al.

Epilepsia, 2026

Small SNPs, Big Effects: A Review of Single Nucleotide Variations and Polymorphisms in Key Genes Associated With Autism Spectrum Disorder.

Srinath S et al.

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience, 2025

Prioritizing de novo potential non-canonical splicing variants in neurodevelopmental disorders.

Li K et al.

Ebiomedicine, 2024

38113761 (PubMed )
Supplement: mmc2.xlsx › Table_S4

Gene variant effects across sodium channelopathies predict function and guide precision therapy.

Brunklaus A et al.

Brain : a Journal of Neurology, 2022

35037686 (PubMed )
Supplement: awac006_Supplementary_Data.pdf

Single-cell transcriptome identifies molecular subtype of autism spectrum disorder impacted by de novo loss-of-function variants regulating glial cells.

Nassir N et al.

Human Genomics, 2021

34802461 (PubMed )
Supplement: 40246_2021_368_MOESM2_ESM.xlsx › DbMS-non_synonymous_ex

Sodium channelopathies of skeletal muscle and brain.

Mantegazza M et al.

Physiological Reviews, 2021

Scn2a severe hypomorphic mutation decreases excitatory synaptic input and causes autism-associated behaviors.

Wang HG et al.

Jci Insight, 2021

Computational analysis of 10,860 phenotypic annotations in individuals with SCN2A-related disorders.

Crawford K et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2021

33731876 (PubMed )
Supplement: 41436_2021_1120_MOESM1_ESM.pdf

Distinct genetic patterns of shared and unique genes across four neurodevelopmental disorders.

Zhang Y et al.

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2021

Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.

Wang T et al.

Nature Communications, 2020

33004838 (PubMed )
Supplement: 41467_2020_18723_MOESM10_ESM.xlsx › Supplementary_Data_8

Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort.

Callaghan DB et al.

Clinical Genetics, 2019

Molecular basis for pore blockade of human Na+ channel Nav1.2 by the μ-conotoxin KIIIA.

Pan X et al.

Science (new York, N.y.), 2019

30765605 (PubMed )
Supplement: aaw2999-pan-sm.pdf

Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.

Begemann A et al.

Molecular Medicine (cambridge, Mass.), 2019

30813884 (PubMed )
Supplement: 10020_2019_73_MOESM1_ESM.docx

Progress in Understanding and Treating SCN2A-Mediated Disorders.

Sanders SJ et al.

Trends in Neurosciences, 2018

Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures.

Ben-Shalom R et al.

Biological Psychiatry, 2017

De novo genic mutations among a Chinese autism spectrum disorder cohort.

Wang T et al.

Nature Communications, 2016

27824329 (PubMed )
Supplement: ncomms13316-s7.xlsx › Supplementary_Data_6

Synaptic, transcriptional and chromatin genes disrupted in autism.

De Rubeis S et al.

Nature, 2014

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."